Compound Evidence File
#EC-2026-0945
Lipo-C FOCUS 425mg
Filed under Injectable Oils. The bureau holds 126 laboratory returns for this compound from 40 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.
Cross-Index
Subjects Shipping This Compound
40 SUBJECTS| Subject | Grade | Samples | Mean | Min | Max | First seen | Last seen |
|---|---|---|---|---|---|---|---|
| Hubei JianxiangCASE #VI-2026-0048 | A | 4 | 10.0 | 9.9 | 10.0 | 26 Feb 2026 | 15 May 2026 |
| Shanghai Sigma AudleyCASE #VI-2026-0505 | A | 4 | 10.0 | 10.0 | 10.0 | 18 Mar 2026 | 8 Jun 2026 |
| Thermo Fisher ScientificCASE #VI-2026-0142 | A | 4 | 10.0 | 9.9 | 10.0 | 8 Feb 2026 | 2 Jul 2026 |
| AsymchemCASE #VI-2026-0091 | A | 4 | 10.0 | 9.9 | 10.0 | 16 Jun 2026 | 16 Aug 2026 |
| Shanghai ERP BiotechnologyCASE #VI-2026-0936 | A | 3 | 10.0 | 9.9 | 10.0 | 12 May 2026 | 1 Jun 2026 |
| BachemCASE #VI-2026-0314 | A | 3 | 10.0 | 9.9 | 10.0 | 28 Jan 2026 | 6 Jun 2026 |
| Flourishglobal PeptideCASE #VI-2026-0630 | A | 3 | 10.0 | 10.0 | 10.0 | 17 Mar 2026 | 21 Jun 2026 |
| Shanghai Wibson BiotechnologyCASE #VI-2026-0379 | A | 3 | 10.0 | 9.9 | 10.0 | 1 Jan 2026 | 10 Jul 2026 |
| WuXi TIDESCASE #VI-2026-0335 | A | 3 | 10.0 | 9.9 | 10.0 | 13 May 2026 | 24 Jul 2026 |
| AmbioPharmCASE #VI-2026-0177 | A | 3 | 10.0 | 10.0 | 10.0 | 7 Apr 2026 | 15 Jun 2026 |
| SinoPepCASE #VI-2026-0387 | A | 2 | 10.0 | 10.0 | 10.0 | 23 Jun 2026 | 7 Aug 2026 |
| HomopeptideCASE #VI-2026-0760 | A | 5 | 9.9 | 9.9 | 10.0 | 24 May 2026 | 24 May 2026 |
| Tianjin Finder Chemical TFCCASE #VI-2026-0693 | A | 5 | 9.9 | 9.9 | 10.0 | 14 Nov 2025 | 16 Apr 2026 |
| Sangon BioCASE #VI-2026-0671 | A | 4 | 9.9 | 9.9 | 10.0 | 26 Feb 2026 | 28 May 2026 |
| Kerui PeptidesCASE #VI-2026-0626 | A | 4 | 9.9 | 9.9 | 9.9 | 25 Jan 2026 | 8 Jun 2026 |
| Mokemei BiotechnologyCASE #VI-2026-0540 | A | 4 | 9.9 | 9.9 | 10.0 | 20 Feb 2026 | 8 Jul 2026 |
| PolyPeptide GroupCASE #VI-2026-0143 | A | 4 | 9.9 | 9.9 | 10.0 | 24 Apr 2026 | 16 Jul 2026 |
| JEEP PeptidesCASE #VI-2026-0457 | A | 3 | 9.9 | 9.9 | 9.9 | 6 Dec 2025 | 9 Apr 2026 |
| GenScript PeptidesCASE #VI-2026-0860 | A | 3 | 9.9 | 9.9 | 10.0 | 20 Mar 2026 | 10 Aug 2026 |
| Sigma-AldrichCASE #VI-2026-0829 | A | 3 | 9.9 | 9.9 | 10.0 | 21 Feb 2026 | 8 Aug 2026 |
| QYAOBIOCASE #VI-2026-0861 | A | 2 | 9.9 | 9.9 | 10.0 | 22 Apr 2026 | 16 May 2026 |
| Chinese Peptide CompanyCASE #VI-2026-0184 | A | 2 | 9.9 | 9.9 | 10.0 | 13 Nov 2025 | 19 May 2026 |
| Hybio PharmaceuticalCASE #VI-2026-0065 | A | 2 | 9.9 | 9.9 | 10.0 | 9 Aug 2026 | 17 Aug 2026 |
| Qingdao Sigma Chemical QSCCASE #VI-2026-0538 | A | 8 | 8.8 | 6.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Shanghai Sigma Audley SSACASE #VI-2026-0486 | A | 6 | 8.8 | 7.8 | 10.0 | 24 May 2026 | 24 May 2026 |
| Rayshine Peptide BiochemicalsCASE #VI-2026-0545 | X | 1 | 8.6 | 8.6 | 8.6 | 13 Jun 2025 | 13 Jun 2025 |
| Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594 | A | 7 | 8.2 | 7.0 | 9.7 | 21 May 2026 | 21 May 2026 |
| Glbiochem (Shanghai)CASE #VI-2026-0704 | A | 4 | 8.2 | 6.4 | 9.4 | 23 May 2026 | 23 May 2026 |
| Tianjin Ruiwang New Material Technology CoCASE #VI-2026-0192 | X | 10 | 8.0 | 6.4 | 9.6 | 3 Jul 2025 | 24 May 2026 |
| Regenerative ResearchCASE #VI-2026-0349 | X | 1 | 7.2 | 7.2 | 7.2 | 14 Jan 2025 | 14 Jan 2025 |
| Forever Young PharmacyCASE #VI-2026-0654 | X | 1 | 7.2 | 7.2 | 7.2 | 11 Jun 2025 | 11 Jun 2025 |
| Richards Biotech Simply RichardsCASE #VI-2026-0307 | X | 1 | 7.2 | 7.2 | 7.2 | 7 May 2025 | 7 May 2025 |
| Nantong Guangyuan Chemical GYCCASE #VI-2026-0284 | A | 3 | 6.7 | 6.3 | 7.2 | 25 May 2026 | 25 May 2026 |
| Yongkang Nuoao Trading CoCASE #VI-2026-0646 | X | 1 | 6.6 | 6.6 | 6.6 | 25 Apr 2025 | 25 Apr 2025 |
| Welon Peptide SolutionsCASE #VI-2026-0478 | X | 1 | 5.3 | 5.3 | 5.3 | 27 Feb 2025 | 27 Feb 2025 |
| Eros PeptidesCASE #VI-2026-0918 | X | 1 | 5.2 | 5.2 | 5.2 | 2 Apr 2025 | 2 Apr 2025 |
| Wolverine PeptidesCASE #VI-2026-0262 | X | 1 | 4.6 | 4.6 | 4.6 | 16 Mar 2025 | 16 Mar 2025 |
| Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228 | X | 1 | 4.2 | 4.2 | 4.2 | 11 Jun 2025 | 11 Jun 2025 |
| Advanced Technology and IndustrialCASE #VI-2026-0133 | X | 1 | 3.1 | 3.1 | 3.1 | 2 Jul 2025 | 2 Jul 2025 |
| Swiss ChemsCASE #VI-2026-0030 | X | 1 | 2.9 | 2.9 | 2.9 | 8 Jul 2025 | 8 Jul 2025 |
Open any subject to view the batch-level evidence for Lipo-C FOCUS 425mg alone.